Aurinia Renal Assessments 2: Aurinia Renal Response in Lupus With Voclosporin (AURORA2)
Diseases of the Kidney & Urinary Tract
What is the purpose of this trial?
The purpose of this study is assess the long-term safety and tolerability of voclosporin compared with placebo for up to an additional 24 months following completion of treatment in the AURORA 1 study in subjects with lupus nephritis (LN).
- Ages18 - 75 years
- Trial withAurinia Pharmaceuticals, Inc.
- Start Date04/01/2019
- End Date08/30/2021
- Last Updated04/08/2019
- Study HIC#2000024835